A team of paleogeneticists is a winner of the 2024 Gizmodo Science Fair for recovering RNA from a museum specimen of a ...

TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribe™ RNA ...

"This could be a game-changer for treating complex conditions where targeting multiple pathways is beneficial, such as cancer ...

Italian biotech Aptadir Therapeutics has launched with the promise that its pipeline of preclinical RNA inhibitors could ...

Researchers developed a quick and affordable whole-blood assay to detect autoantibodies against type I IFNs, enabling rapid ...

Recent research from the University of Seville indicates that RNA, the molecule that is responsible for the origin of life, ...

Aptadir Therapeutics (Aptadir), a biotech company developing RNA inhibitor-based therapeutics for treating intractable ...

Aptadir Therapeutics, a biotech focused on RNA inhibitor therapies for cancer and genetic conditions, has launched with $1.6 ...

Goldman Sachs has initiated coverage on Avidity Biosciences with a Buy rating and a $59 price target, citing ...

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each ...

A team at the Hübner and Diecke Labs at the Max Delbrück Center has shown how human and non-human primate hearts differ ...